Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq
Background: Optimal prescribing of secondary prevention medications after acute coronary syndrome (ACS) events has been shown to reduce morbidity and mortality. However, it is unknown whether these medications are optimally prescribed at discharge from acute care in Iraq. Objective: To evaluate whe...
Main Authors: | Nassr OA, Forsyth P, Johnson CF |
---|---|
Format: | Article |
Language: | English |
Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2019-03-01
|
Series: | Pharmacy Practice |
Subjects: | |
Online Access: | https://www.pharmacypractice.org/journal/index.php/pp/article/view/1372 |
Similar Items
-
Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01) -
Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine
by: S. Yu. Martsevich
Published: (2020-05-01) -
Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case
by: N G Poteshkina, et al.
Published: (2014-12-01) -
Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension
by: Jinwoo Lee, et al.
Published: (2021-03-01) -
بررسی تأثیر ترکیب مهار کنندههای آنزیم مبدل آنژیوتانسین و بلوک کنندههای گیرندهی آنژیوتانسین بر پیشرفت بیماری کلیوی در بیماران مبتلا به دیابت نوع 2 در مقایسه با تجویز هر یک از این دو دارو به تنهایی
by: Houshang Sanadgol, et al.
Published: (2016-04-01)